Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck?

Head and neck squamous cell carcinomas (SCCHN) are not rare malignancies and account for 7% of all solid tumors. Prognosis of SCCHN patients strongly depends on tumor extension, site of onset, and genetics. Advanced disease (recurrent/metastatic) is associated with poor prognosis, with a median over...

Full description

Bibliographic Details
Main Authors: Francesco Longo, Francesco Perri, Francesco Caponigro, Giuseppina Della Vittoria Scarpati, Agostino Guida, Ettore Pavone, Corrado Aversa, Paolo Muto, Mario Giuliano, Franco Ionna, Raffaele Solla
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/2781